about
Immune mechanisms of protection: can adjuvants rise to the challenge?Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stabilityPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesVaccines for the 21st centuryVaccines: the Fourth CenturyNew adjuvanted vaccines in pregnancy: what is known about their safety?De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines.CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxisContribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infantsInterleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity.Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro.Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesFormulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.Innate immunostimulatory properties of allergens and their relevance to food allergy.Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivoImpact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.Dendritic cell immunotherapy for HIV infection: from theory to reality.Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.Influenza virosomes as a vaccine adjuvant and carrier system.IκB kinase regulation of the TPL-2/ERK MAPK pathway.Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.Current progress in development of hepatitis C virus vaccines.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.The impact of size on particulate vaccine adjuvants.Polyethylenimine-based micro/nanoparticles as vaccine adjuvants.Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Corynebacterium pyruviciproducens, as an immune modulator, can promote the activity of macrophages and up-regulate antibody response to particulate antigen.
P2860
Q21245319-C638248E-F5EA-4424-B84F-2AD6F9C523B6Q24634332-1761A692-DD33-47BC-9D0A-0ED3E39B068AQ26852816-A6D99597-053C-48D0-9A80-0650418A8792Q27007529-EF0B5E8D-ADD9-4DF4-AE3B-94BE097B959FQ27490454-4C64821A-581B-4FD3-802F-6F8A684EE798Q30396657-DDCA9261-3CED-42B1-B705-CAA9987115D2Q30403833-4A548B8B-483C-4E45-9AA0-A9173872922EQ31088337-5EF3FD72-8CD7-4D33-A609-1EA8B8A82314Q33669280-D284ED75-7C49-4B2D-8C08-341D92CA94F7Q33933077-4FA5E066-D519-43E0-8BE6-1747623D9C34Q34287383-F29BC605-F248-4D56-95ED-8A663F6FFD3EQ34416470-7A679A81-03F0-4A0C-A58F-63676A0EC489Q34438046-44439F66-843A-4436-919F-4E1B975F381FQ34481835-549EE719-10B8-422B-A180-D2BE96401040Q34557185-E9EE3DF6-5BD3-4F8C-AE25-F9B273310DD5Q34584142-5CA4A3D9-01A2-4F19-905E-766A1008052EQ34960453-E879E107-4318-47C0-A6D9-5DCBBBB3904DQ34990010-1E681E69-7982-43DF-B161-B936BF126D10Q35100779-B7FA6D96-DA18-4809-A638-4894C4683546Q35593603-A7A0AA1E-FF62-4C32-AA53-83404236CD57Q36283976-4A89E990-708C-475A-8D8D-04FC6819C2F6Q36395541-4C0D5BE0-6F0A-451D-BC53-4823BFCFE02FQ36951826-42AB2EF9-73AA-4530-B2B2-D346D9AFB495Q37096865-20A9326A-77CB-4847-8546-FCA5FF96A535Q37110147-7CEEB803-C8D8-418C-9428-FC3331C8428FQ37372321-C61C04B8-94C7-4B22-A44D-62687C587A95Q37717709-A0967599-1730-4940-8BCC-653951153728Q37773251-F679C88F-A92B-4824-B65B-806F6F701514Q37773295-698A52B6-79EF-4AE7-8DE0-9969091CAD7FQ37867100-F9B3806F-6D9D-42FA-9E77-2B177DB5D214Q37995683-B1C566A0-40FE-4332-B697-B1FFDD9B80F5Q38032881-0AD7F932-9CF7-4C5F-88DF-8A59037F08D3Q38068469-6F4841AD-BFC7-469F-AC76-BDF86221BE89Q38120201-919730F9-1AAD-4481-A0AF-0F6B6EC97E4DQ38264288-A0787F84-935A-4DAE-81F7-D10FDF9D2760Q38296080-D38FCC72-B79C-41B8-B60A-22F6CFBBB07BQ38641439-5D61A5E7-55E9-4000-94A5-FA6D9E7147FDQ38783989-401F51A7-A02C-4632-9B1F-6EB57F9814E1Q39049093-7CE62071-7E9E-427A-A7E9-DD4F4A0B7115Q39226260-D45062F0-3914-4D5D-95F5-6D5DED18B210
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunology of TLR-independent vaccine adjuvants.
@en
Immunology of TLR-independent vaccine adjuvants.
@nl
type
label
Immunology of TLR-independent vaccine adjuvants.
@en
Immunology of TLR-independent vaccine adjuvants.
@nl
prefLabel
Immunology of TLR-independent vaccine adjuvants.
@en
Immunology of TLR-independent vaccine adjuvants.
@nl
P1476
Immunology of TLR-independent vaccine adjuvants.
@en
P2093
Ennio De Gregorio
P304
P356
10.1016/J.COI.2009.05.003
P50
P577
2009-06-01T00:00:00Z